Home > Investors
Investors
Build a smarter, safer and healthier future
Future
Outlook
Current
Business in Sweden
Sweden offers some of the best healthcare in the world and Swedish life science companies are global leaders in their field. Interest in commercial opportunities in this sector has never been higher. The Stockholm region has a complete ecosystem including recognised universities, incubators, science parks and testbeds.
Outlook by Sector
Promising investment opportunities
$390.7 billion by 2024
$1170 billion by 2021
$30.80 billion by 2020
$172.6 billion by 2022
Metabolic Diseases
$88.93 billion by 2025
Commercial
Life science projects and cross-disciplinary research
We invite partners from industry and academia to support ideas that can reshape the way we solve problems for major diseases.
© 2019 Nordic Joincells AB | This site uses cookies